Dermatology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
J Dtsch Dermatol Ges. 2010 Dec;8(12):985-8. doi: 10.1111/j.1610-0387.2010.07487.x. Epub 2010 Aug 13.
Reports of treatment failure of head lice have become increasingly common. Oral ivermectin has been proposed as a potential alternative for the treatment of head lice infestation. The aim of this study was to compare the efficacy of oral ivermectin with topical malathion lotion in the treatment of head lice.
Eighty apparently healthy children with head lice infestation were randomly assigned to 2 groups, with 40 patients in each. The first group received oral ivermectin as a single dose of 200 μg/kg and the second group received single topical application of malathion lotion 0.5%. Follow up visits were done at days 8, 15 and 29. A second dose of either drug was given at day 8 in case of treatment failure.
After a single dose, complete cure was achieved in 77.5% and 87.5% of ivermectin and malathion groups respectively. After the second dose for nonresponders, the cure rate increased to 92.5% in the ivermectin group and 95% in the malathion group. No major adverse effects were observed in either group.
Oral ivermectin is a promising effective approach for the treatment of head lice and could be an ideal substitute for conventional pediculicides.
越来越多的报告表明头虱的治疗失败案例不断增加。口服伊维菌素已被提议作为治疗头虱感染的潜在替代药物。本研究旨在比较口服伊维菌素与外用马拉硫磷洗剂治疗头虱的疗效。
80 例明显健康的头虱感染儿童被随机分为两组,每组 40 例。第一组给予口服伊维菌素,剂量为 200μg/kg 单次剂量,第二组给予 0.5%马拉硫磷洗剂单次外用。在第 8、15 和 29 天进行随访。如果治疗失败,在第 8 天给予两种药物的第二剂。
单次给药后,伊维菌素组和马拉硫磷组的完全治愈率分别为 77.5%和 87.5%。对于无反应者给予第二剂后,伊维菌素组的治愈率增加到 92.5%,马拉硫磷组的治愈率增加到 95%。两组均未观察到主要不良反应。
口服伊维菌素是一种有前途的有效治疗头虱的方法,可作为传统灭虱剂的理想替代品。